Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling

Medicine & Life Sciences

• Epstein-Barr virus EBV-associated membrane antigen 100%
• Phosphatidylinositol 3-Kinase 66%
• Actin Cytoskeleton 64%
• Membrane Proteins 54%
• Cell Survival 49%
• Tumor Necrosis Factor Receptor-Associated Peptides and Proteins 10%
• rho GTP-Binding Proteins 9%
• Stress Fibers 9%
• Epstein-Barr Virus Infections 8%
• 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 8%
• Tumor Necrosis Factor Receptors 8%
• NF-kappa B 7%
• Mitogen-Activated Protein Kinases 7%
• Actins 6%
• Phosphotransferases 5%
• Phosphorylation 5%
• Lipids 4%

Chemistry

• Phosphatidylinositol 78%
• Cell Viability 64%
• Filament 64%
• Protein 27%
• LY294002 10%
• Phosphatidylinositol 3 Kinase Inhibitor 10%
• Oncogenic 8%
• Lipid 4%
• Chemical Transformation 3%
• Molecule 2%